Narender Annapureddy, MD
Basic profileNarender Annapureddy is a Rheumatology/Immunology physician affiliated with Vanderbilt University. OpenAlex indexes 70 publications with 878 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20251 payment$650
- AstraZeneca Pharmaceuticals LPProgram year20251 payment$96
- GlaxoSmithKline, LLC.Program year20244 payments$5,481
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
42.7%TNF inhibitor18%Humira(Cf) Pen59%Enbrel Sureclick41%Part D<11 patientsFolate Analog Metabolic Inhibitor10.5%Methotrexate100%Part D≥24 patients+ 6 more classes in this area
Metabolism & gastrointestinal
15.4%Corticosteroid14%Prednisone100%Part D≥36 patientsAntidiarrheal microorganisms1.5%Folic Acid100%Part D<11 patientsMusculoskeletal
13.4%Nonsteroidal Anti-inflammatory Drug6.9%Diclofenac Sodium71%Nabumetone29%Part D<11 patientsXanthine oxidase inhibitor4.9%Allopurinol100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
William Schaffner, MD
Vanderbilt University
Keith Obstein, MD, MPH
Vanderbilt University
Devika Nair, MD
Vanderbilt University
Andrew Jallouk, MD, PhD
Vanderbilt University
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”